Oceanía · Actualidad · The Mercury

Optiscan’s digital pathology tech hits major US FDA milestone

Publicado por The Mercury · Australia hace 16 h

Optiscan Imaging has hit a major US regulatory milestone, lodging its FDA 510(k) submission for InForm and moving the digital pathology device into formal review.

Leer el artículo completo en The Mercury Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.themercury.com.au)

Optiscan’s digital pathology tech hits major US FDA milestone

También te puede interesar

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns

Optiscan’s digital pathology tech hits major US FDA milestone

Compartir

También te puede interesar

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns